MHealth

From WikiMD's WELLNESSPEDIA

mHealth (also written as m-health or mobile health) is a term used for the practice of medicine and public health supported by mobile devices. The term is most commonly used in reference to using mobile communication devices, such as mobile phones, tablet computers and PDAs, and wearable devices such as smart watches, for health services, information, and data collection.

History[edit]

The concept of mHealth began to develop with the advent of telemedicine. With the proliferation of mobile devices and wireless technology, mHealth has become a significant element of healthcare delivery.

Applications[edit]

mHealth applications include the use of mobile devices in collecting community and clinical health data, delivery of healthcare information to practitioners, researchers, and patients, real-time monitoring of patient vital signs, and direct provision of care (via mobile telemedicine).

Challenges[edit]

While mHealth certainly has potential for improving healthcare delivery, it also has potential challenges that need to be addressed. These include issues related to data security, infrastructure requirements, and ensuring quality and efficacy of interventions.

Future[edit]

The future of mHealth lies in its potential to leverage widespread mobile technology and connectivity to deliver efficient, high-quality healthcare services. This includes the potential for real-time patient monitoring, telemedicine, and improved access to healthcare information and services.

See also[edit]

References[edit]


External links[edit]

  • World Health Organization mHealth Report


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.